211 related articles for article (PubMed ID: 14601152)
21. The relationship between reliability and size of willingness-to-pay values: a qualitative insight.
Smith RD
Health Econ; 2007 Feb; 16(2):211-6. PubMed ID: 16929470
[TBL] [Abstract][Full Text] [Related]
22. Values for preventing influenza-related morbidity and vaccine adverse events in children.
Prosser LA; Bridges CB; Uyeki TM; Rêgo VH; Ray GT; Meltzer MI; Schwartz B; Thompson WW; Fukuda K; Lieu TA
Health Qual Life Outcomes; 2005 Mar; 3():18. PubMed ID: 15780143
[TBL] [Abstract][Full Text] [Related]
23. Eliciting several willingness to pay in a single contingent valuation survey: application to health care.
Luchini S; Protière C; Moatti JP
Health Econ; 2003 Jan; 12(1):51-64. PubMed ID: 12483760
[TBL] [Abstract][Full Text] [Related]
24. Are any numbers better than no numbers? The sorry state of willingness-to-pay and some major methodological shortcomings.
Burrows C; Brown K
Aust Health Rev; 1992; 15(2):135-44. PubMed ID: 10119045
[TBL] [Abstract][Full Text] [Related]
25. Theory and methods of economic evaluation of health care.
Johannesson M
Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
[No Abstract] [Full Text] [Related]
26. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
[TBL] [Abstract][Full Text] [Related]
27. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
28. The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?
Smith RD
Health Econ; 2007 Dec; 16(12):1319-32. PubMed ID: 17328037
[TBL] [Abstract][Full Text] [Related]
29. Willingness to pay for antihypertensive therapy--results of a Swedish pilot study.
Johannesson M; Jönsson B; Borgquist L
J Health Econ; 1991; 10(4):461-73. PubMed ID: 10117014
[TBL] [Abstract][Full Text] [Related]
30. Modelling the monetary value of a QALY: a new approach based on UK data.
Mason H; Jones-Lee M; Donaldson C
Health Econ; 2009 Aug; 18(8):933-50. PubMed ID: 18855880
[TBL] [Abstract][Full Text] [Related]
31. Willingness to pay and cost of illness for changes in health capital depreciation.
Ried W
Health Econ; 1996; 5(5):447-67. PubMed ID: 8922972
[TBL] [Abstract][Full Text] [Related]
32. A review of the use of health status measures in economic evaluation.
Brazier J; Deverill M; Green C; Harper R; Booth A
Health Technol Assess; 1999; 3(9):i-iv, 1-164. PubMed ID: 10392311
[No Abstract] [Full Text] [Related]
33. Life-cycle preferences over consumption and health: a comment on Bleichrodt and Quiggin.
Klose T
J Health Econ; 2002 Jan; 21(1):161-6; discussion 167-8. PubMed ID: 11845922
[TBL] [Abstract][Full Text] [Related]
34. The bias against new innovations in health care: value uncertainty and willingness to pay.
Walton SM; Graves PE; Mueser PR; Dow JK
Value Health; 2002; 5(2):67-70. PubMed ID: 11918821
[TBL] [Abstract][Full Text] [Related]
35. Estimating an EQ-5D population value set: the case of Japan.
Tsuchiya A; Ikeda S; Ikegami N; Nishimura S; Sakai I; Fukuda T; Hamashima C; Hisashige A; Tamura M
Health Econ; 2002 Jun; 11(4):341-53. PubMed ID: 12007165
[TBL] [Abstract][Full Text] [Related]
36. A second opinion. Cost-utility analysis and varying preferences for health.
Mooney G; Jan S
Health Policy; 1997 Sep; 41(3):201-3; discussion 203-5. PubMed ID: 10170089
[No Abstract] [Full Text] [Related]
37. Incorporating quality of life changes into economic evaluations of health care: an overview.
Blumenschein K; Johannesson M
Health Policy; 1996 May; 36(2):155-66. PubMed ID: 10158766
[TBL] [Abstract][Full Text] [Related]
38. Waiting time and doctor shopping in a mixed medical economy.
Yeung RY; Leung GM; McGhee SM; Johnston JM
Health Econ; 2004 Nov; 13(11):1137-44. PubMed ID: 15386684
[TBL] [Abstract][Full Text] [Related]
39. The contingent ranking method--a feasible and valid method when eliciting preferences for health care?
Slothuus U; Larsen ML; Junker P
Soc Sci Med; 2002 May; 54(10):1601-9. PubMed ID: 12061490
[TBL] [Abstract][Full Text] [Related]
40. QALYs, standard gambles, and the expected budget constraint.
Blomqvist A
J Health Econ; 2002 Mar; 21(2):181-95. PubMed ID: 11939237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
